Selexipag
| CAS No. | 475086-01-2 |
|---|---|
| MDL No. | MFCD10567093 |
| MF | C26H32N4O4S |
| MW | 496.60 |
| InChI Key | QXWZQTURMXZVHJ-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Selexipag is a pyrazine derivative, specifically N-(methanesulfonyl)-2-{4-[(propan-2-yl)(pyrazin-2-yl)amino]butoxy}acetamide, with two phenyl groups at positions 5 and 6 of the pyrazine ring. It is an orphan drug used to treat pulmonary arterial hypertension and functions as a prodrug for ACT-333679. It acts as a prostacyclin receptor agonist, platelet aggregation inhibitor, and vasodilator. Chemically, it is a monocarboxylic acid amide, ether, aromatic amine, tertiary amine, and N-sulfonylcarboxamide. It is functionally related to ACT-333679.
| CAS No. | 475086-01-2 |
|---|---|
| Product Name | Selexipag |
Biological Targets
PTGIR
Associated Conditions
idiopathic pulmonary arterial hypertension·pulmonary arterial hypertension·pulmonary hypertension·Recurrent thrombophlebitis
* The information provided here is compiled from public sources and is for reference only.